“…[12][13][14][15] A number of studies have been presented providing evidence for associations between these IL-10 promoter variants and infectious or autoimmune diseases, including meningococcal infection, fatal septicemia, systemic lupus erythematodes, reactive arthritis, psoriasis, Sjogreń s syndrome, and multiple sclerosis. 10,12,[16][17][18][19][20] So far, it has not been studied, however, whether IL-10 promoter variants influence lymphocyte proliferation upon antigen stimulation, a major regulatory function attributed to IL-10.…”